Imagion Biosystems Limited (ASX:IBX)
0.0120
-0.0010 (-7.69%)
Aug 11, 2026, 4:10 PM AEST
Imagion Biosystems Market Cap
Imagion Biosystems has a market cap or net worth of 6.48 million as of August 11, 2026. Its market cap has increased by 114.54% in one year.
Market Cap
6.48M
Enterprise Value
7.32M
Revenue
73.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 6.48M, a decrease of -80.16%. That is a compound annual growth rate of -16.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 6.48M | -46.69% |
| Dec 31, 2025 | 12.15M | 162.45% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 441.54M |
| Healius | 297.72M |
| Monash IVF Group | 266.90M |
| Cryosite | 58.57M |
| Microba Life Sciences | 34.42M |
| Rhythm Biosciences | 34.33M |
| INOVIQ | 28.86M |
| BCAL Diagnostics | 23.96M |